Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Vanguard Group Inc. Sells 283,775 Shares of Edwards Lifesciences Corporation $EW
Vanguard Group Inc. reduced its stake in Edwards Lifesciences Corporation by 0.4% in the fourth quarter, selling 283,775 shares but still holding over 70 million shares valued at approximately $5.97 billion. Despite this sale, Edwards Lifesciences reported strong Q1 earnings, beating analyst estimates and raising its full-year 2026 guidance, along with announcing a $500M accelerated share repurchase program. The company faces some insider selling and cost-of-sales pressures, but analysts generally maintain a “Moderate Buy” rating with a consensus price target around $95.39.